Recipient, donor and transplantation characteristics for the entire cohort and for those with and without a surgical site complication within 30 days after transplantation*
| Variable | No. (%) of patients† | ||
|---|---|---|---|
| Overall n = 1501 | No surgical site complication n = 1406 | Surgical site complication n = 59 | |
| Recipient age at transplantation, mean ± SD, yr | 50.8 ± 13.4 | 50.7 ± 13.5 | 55.1 ± 11.7 |
| Recipient sex | |||
| Male | 905 (60.3) | 845 (60.1) | 44 (74.6) |
| Female | 596 (39.7) | 561 (39.9) | 15 (25.4) |
| Recipient race | |||
| Nonwhite | — | 482 (34.3) | 24 (40.7) |
| White | — | 820 (58.3) | 31 (52.5) |
| Missing | — | 104 (7.4) | 4 (6.8) |
| Recipient body mass index, mean ± SD (n = 1448) | 27.0 ± 5.5 | 26.9 ± 5.5 | 29.7 ± 6.3 |
| Recipient history of diabetes | |||
| No | 1049 (69.9) | 994 (70.7) | 29 (49.2) |
| Yes | 451 (30.0) | 411 (29.2) | 30 (50.8) |
| Missing | 1 (0.1) | 1 (0.1) | 0 (0.0) |
| Recipient history of cardiovascular disease | |||
| No | 1091 (72.7) | 1028 (73.1) | 38 (64.4) |
| Yes | 409 (27.2) | 377 (26.8) | 21 (35.6) |
| Missing | 1 (0.1) | 1 (0.1) | 0 (0.0) |
| Median time receiving dialysis (IQR), yr | 3.2 (1.2–5.8) | 3.2 (1.2–5.8) | 3.6 (2.3–5.5) |
| Median length of stay (IQR), d (n = 1465) | 9 (7–12) | 8 (7–12) | 12 (8–20) |
| Peak panel reactive antibody, % | |||
| 0 | — | 660 (46.9) | 21 (35.6) |
| > 0 | — | 745 (53.0) | 38 (64.4) |
| Missing | — | 1 (0.1) | 0 (0.0) |
| Donor age, mean ± SD, yr (n = 1499) | 47.2 ± 14.4 | 47.0 ± 14.3 | 52.5 ± 14.2 |
| Donor sex | |||
| Male | — | 701 (49.9) | 37 (62.7) |
| Female | — | 699 (49.7) | 22 (37.3) |
| Missing | — | 6 (0.4) | 0 (0.0) |
| Donor type | |||
| Living | 731 (48.7) | 687 (48.9) | 21 (35.6) |
| Deceased, ECD | 256 (17.1) | 233 (16.6) | 20 (33.9) |
| Deceased, non-ECD | 514 (34.2) | 486 (34.6) | 18 (30.5) |
| Induction therapy | |||
| Nondepleting agent | — | 361 (25.7) | 5 (8.5) |
| Depleting agent | — | 1045 (74.3) | 54 (91.5) |
| Calcineurin inhibitor type at discharge | |||
| Tacrolimus | — | 1209 (86.0) | 55 (93.2) |
| Cyclosporine | — | 176 (12.5) | 2 (3.4) |
| Missing | — | 21 (1.5) | 2 (3.4) |
| Cold ischemic time, mean ± SD, h (n = 712)‡ | 11.9 ± 5.2 | 11.8 ± 5.1 | 13.2 ± 6.5 |
| Delayed graft function | — | 280 (19.9) | 21 (35.6) |
| Median duration of surgery (IQR), h (n = 1491) | 2.3 (2.0–2.7) | — | — |
| Median household income (IQR), $ (n = 1312) | 66 412 (49 053–88 996) | 66 358 (49 187–88 935) | 70 853 (44 058–93 153) |
| Transplantation period | |||
| 2005–2009 | 630 (42.0) | 589 (41.9) | 17 (28.8) |
| 2010–2012 | 434 (28.9) | 402 (28.6) | 26 (44.1) |
| 2013–2015 | 437 (29.1) | 415 (29.5) | 16 (27.1) |
ECD = expanded-criteria donor; IQR = interquartile range; SD = standard deviation.
↵* Thirty-six patients were excluded from the cohort since they were lost to follow-up or experienced graft failure during the first 30 days after transplantation, or did not receive induction immunosuppression.
↵† Except where noted otherwise.
↵‡ Deceased donors only.